Coronavirus 2019 (COVID-19) is a highly contagious and deadly disease. Since December 2019, the number of COVID-19 cases has rapidly reported from around the world. Initial serology rapid tests for SARS-CoV-2 antibodies showed a significant number of false negatives results. Other markers are needed so that the medical worker is more sensitive to the suspicion of a COVID-19 infection. This study aimed to assess the high levels of CRP in brain tumor patients as a biomarker of COVID-19 infection.
Eleven brain tumor patients were going to undergo tumor surgery. The SARS-CoV-2 antibodies were negative. There were also no initial symptoms of COVID-19 infection, and patients were scheduled to undergo elective surgical removal of the tumor. During a routine preoperative, we performed the PCR nasopharyngeal swab. All the patients were positive for COVID-19 infection. We also found increased serum CRP levels in all patients.
Key words: High level of CRP, COVID-19, Brain tumor
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
